Tumor hypoxia and cancer progression

Cancer Letters - Tập 237 Số 1 - Trang 10-21 - 2006
Jie Zhou1, Tobias Schmid1, Steffen E. Schnitzer1, Bernhard Brüne1
1Institute of Biochemistry I, Faculty of Medicine, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Semenza, 2004, Hydroxylation of HIF-1: oxygen sensing at the molecular level, Physiology (Bethesda), 19, 176, 10.1152/physiol.00001.2004

Kaelin, 2002, How oxygen makes its presence felt, Genes Dev., 16, 1441, 10.1101/gad.1003602

Pugh, 2003, Regulation of angiogenesis by hypoxia: role of the HIF system, Nat. Med., 9, 677, 10.1038/nm0603-677

Jaakkola, 2001, Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation, Science, 292, 468, 10.1126/science.1059796

Ivan, 2001, HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science, 292, 464, 10.1126/science.1059817

Epstein, 2001, EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation, Cell, 107, 43, 10.1016/S0092-8674(01)00507-4

Bruick, 2001, A conserved family of prolyl-4-hydroxylases that modify HIF, Science, 294, 1337, 10.1126/science.1066373

Maxwell, 1999, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, 399, 271, 10.1038/20459

Salceda, 1997, Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions, J. Biol. Chem., 272, 22642, 10.1074/jbc.272.36.22642

Huang, 1998, Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway, Proc. Natl Acad. Sci. USA, 95, 7987, 10.1073/pnas.95.14.7987

Roach, 1995, Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes, Nature, 375, 700, 10.1038/375700a0

Hirsila, 2003, Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor, J. Biol. Chem., 278, 30772, 10.1074/jbc.M304982200

Gerald, 2004, JunD reduces tumor angiogenesis by protecting cells from oxidative stress, Cell, 118, 781, 10.1016/j.cell.2004.08.025

Lando, 2002, Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch, Science, 295, 858, 10.1126/science.1068592

Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, 3, 721, 10.1038/nrc1187

Greijer, 2004, The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis, J. Clin. Pathol., 57, 1009, 10.1136/jcp.2003.015032

O'Reilly, 1996, Angiostatin induces and sustains dormancy of human primary tumors in mice, Nat. Med., 2, 689, 10.1038/nm0696-689

An, 1998, Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha, Nature, 392, 405, 10.1038/32925

Wenger, 1998, Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction, Cancer Res., 58, 5678

Koumenis, 2001, Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation, Mol. Cell. Biol., 21, 1297, 10.1128/MCB.21.4.1297-1310.2001

Achison, 2003, Hypoxia attenuates the p53 response to cellular damage, Oncogene, 22, 3431, 10.1038/sj.onc.1206434

Pan, 2004, p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment, Oncogene, 23, 4975, 10.1038/sj.onc.1207657

Hansson, 2002, Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53, Proc. Natl Acad. Sci. USA, 99, 10305, 10.1073/pnas.122347199

Chen, 2003, Direct interactions between HIF-1alpha and Mdm2 modulate p53 function, J. Biol. Chem., 278, 13595, 10.1074/jbc.C200694200

Ravi, 2000, Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha, Genes Dev., 14, 34, 10.1101/gad.14.1.34

Schmid, 2004, p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1), Biochem. J., 380, 289, 10.1042/bj20031299

Blagosklonny, 1998, p53 inhibits hypoxia-inducible factor-stimulated transcription, J. Biol. Chem., 273, 11995, 10.1074/jbc.273.20.11995

Fei, 2004, Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth, Cancer Cell, 6, 597, 10.1016/j.ccr.2004.10.012

Bruick, 2000, Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia, Proc. Natl Acad. Sci. USA, 97, 9082, 10.1073/pnas.97.16.9082

Vande Velde, 2000, BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore, Mol. Cell. Biol., 20, 5454, 10.1128/MCB.20.15.5454-5468.2000

Kothari, 2003, BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF, Oncogene, 22, 4734, 10.1038/sj.onc.1206666

Okami, 2004, Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer, Cancer Res., 64, 5338, 10.1158/0008-5472.CAN-04-0089

Kubasiak, 2002, Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3, Proc. Natl Acad. Sci. USA, 99, 12825, 10.1073/pnas.202474099

Sowter, 2001, HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors, Cancer Res., 61, 6669

Kim, 2004, BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha, J. Exp. Med., 199, 113, 10.1084/jem.20030613

Papandreou, 2005, Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment, Cancer Res., 65, 3171, 10.1158/0008-5472.CAN-04-3395

Dennis, 1991, Protons in ischemia: where do they come from; where do they go to?, J. Mol. Cell. Cardiol., 23, 1077, 10.1016/0022-2828(91)91642-5

Hochachka, 1983, Protons and anaerobiosis, Science, 219, 1391, 10.1126/science.6298937

Zheng, 2005, Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury, FASEB J., 19, 109, 10.1096/fj.04-2607fje

Webster, 1999, Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53, J. Clin. Invest., 104, 239, 10.1172/JCI5871

Maxwell, 1997, Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth, Proc. Natl Acad. Sci. USA, 94, 8104, 10.1073/pnas.94.15.8104

Jiang, 1997, V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression, Cancer Res., 57, 5328

Ryan, 1998, HIF-1 alpha is required for solid tumor formation and embryonic vascularization, EMBO J., 17, 3005, 10.1093/emboj/17.11.3005

Carmeliet, 1998, Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis, Nature, 394, 485, 10.1038/28867

Zhang, 2004, Enhancement of hypoxia-induced tumor cell death In vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha, Cancer Res., 64, 8139, 10.1158/0008-5472.CAN-03-2301

Yu, 2004, Antiapoptotic action of hypoxia-inducible factor-1 alpha in human endothelial cells, Lab. Invest., 84, 553, 10.1038/labinvest.3700071

Zhang, 2004, Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas, Int. J. Cancer, 111, 849, 10.1002/ijc.20334

Akakura, 2001, Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation, Cancer Res., 61, 6548

Erler, 2004, Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance, Mol. Cell. Biol., 24, 2875, 10.1128/MCB.24.7.2875-2889.2004

Park, 2002, Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), Biochem. Biophys. Res. Commun., 291, 150, 10.1006/bbrc.2002.6421

Dong, 2001, Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms, J. Biol. Chem., 276, 18702, 10.1074/jbc.M011774200

Piret, 2005, Hypoxia-inducible Factor-1-dependent Overexpression of Myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis, J. Biol. Chem., 280, 9336, 10.1074/jbc.M411858200

Dong, 2004, Hypoxia selection of death-resistant cells. A role for Bcl-X(L), J. Biol. Chem., 279, 9215, 10.1074/jbc.M312225200

Baek, 2000, Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis, Oncogene, 19, 4621, 10.1038/sj.onc.1203814

Liu, 2001, Endothelial cell apoptosis is inhibited by a soluble factor secreted by human colon cancer cells, Int. J. Cancer, 92, 26, 10.1002/1097-0215(200102)9999:9999<::AID-IJC1151>3.0.CO;2-T

Rehman, 2004, Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells, Circulation, 109, 1292, 10.1161/01.CIR.0000121425.42966.F1

Zhang, 2003, Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells, FASEB J., 17, 1709, 10.1096/fj.02-1111fje

Qi, 2003, The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway, Cancer Res., 63, 7076

Walmsley, 2005, Hypoxia-induced neutrophil survival is mediated by HIF-1{alpha}-dependent NF-{kappa}B activity, J. Exp. Med., 201, 105, 10.1084/jem.20040624

Hockel, 2001, Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects, J. Natl Cancer Inst., 93, 266, 10.1093/jnci/93.4.266

Wang, 2002, Hypoxia upregulates Bcl-2 expression and suppresses interferon-gamma induced antiangiogenic activity in human tumor derived endothelial cells, Cancer, 94, 2745, 10.1002/cncr.10520

Piret, 2002, CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2, Ann. NY Acad. Sci., 973, 443, 10.1111/j.1749-6632.2002.tb04680.x

Unruh, 2003, The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy, Oncogene, 22, 3213, 10.1038/sj.onc.1206385

Aebersold, 2001, Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer, Cancer Res., 61, 2911

Birner, 2001, Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy, Clin. Cancer Res., 7, 1661

Koukourakis, 2001, Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy, Cancer Res., 61, 1830

Volm, 2000, Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer, Anticancer Res., 20, 1527